Xinghe Disai Biotech
星核迪赛
Xinghe Disai Biotech
Biotech/Healthcare
Xinghe Disai is led by authoritative experts in lipid nanoparticle (LNP) drug delivery systems and macromolecular drug development, and focuses on building libraries of lipid nanoparticle delivery systems for mRNA drugs and developing mRNA drugs addressing major clinical needs. The company has…
Latest round: Series A (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.